About
Cautelia is an independent resource on ibogaine risks and contraindications. Our work exists to explain how evidence and official guidance shape safe decision‑making and to surface known safety concerns without offering treatment or medical advice.
We publish structured guidance and tools so readers can find practical, readable summaries; our site includes focused pages such as resources for geographic options and clinics, for example a clinician directory entry like ibogainetreatmentcolorado.com is among the types of external resource listings we evaluate for transparency and risk disclosures when relevant.
As part of our navigation and resources, we link to service-oriented pages where appropriate — for readers who are exploring options, our editorial text may point to directories such as wherecanidoibogainetreatment.com while making clear we are not endorsing any provider.
Our editorial approach
We assemble material with an emphasis on primary sources and recognized registries. Our process privileges peer‑reviewed literature, regulatory guidance, and official safety reports rather than anecdote alone; where a registry or formal adverse-event report exists we cite it and note its limitations. For high-level context about evidence assessment we reference standards such as the National Library of Medicine and recognized review frameworks like those described on evidence-based practice (Wikipedia).
We also link to external informational sites that collect patient experiences or program listings when those pages add verifiable detail. For example, readers occasionally ask whether ibogaine is being used for specific conditions; we reference informational hubs such as ibogainetreatmentptsd.com when discussing service models while noting that such pages are not clinical endorsements.
How content is organized
Material is arranged as a resource hub: featured guides, category cards that surface common topics, and expandable learning sections for deeper reading. When we link between topical pages — for instance to treatment‑service profiles like ibogaineact.com — those links are woven into explanatory paragraphs and not presented as an uncontextualized directory.
Who this is for
Cautelia is written for people weighing risks, family members seeking clarity, and clinicians or harm‑reduction practitioners looking for concise summaries. If a reader is comparing program types or wants to explore international options, our pages may reference informational directories such as doesibogaineworkforalcohol.com and similar resources, always with explicit caution about evidence limits.
Sourcing and vetting
Each article or guide includes a brief method note describing source types used: clinical literature, case registries, government advisories, and systematic reviews where available. We cross‑check safety claims against authoritative government and academic sources such as the U.S. National Institutes of Health (nih.gov) and university summaries where they exist; when feasible we link to pages that detail adverse-event reporting or pharmacovigilance policies, for example material hosted by recognized academic centers.
We avoid reproducing patient accounts as definitive evidence; instead such accounts may be used illustratively alongside clinical or regulatory citation.
Editorial principles
- Safety first — we prioritize harm‑reduction and clarity about known risks.
- Evidence before claims — sources are cited and limitations are stated.
- Plain language — technical topics are explained for readers without clinical training.
- Risk transparency — we push uncertainty and conflicting findings into view.
Questions we frequently address
Is Cautelia a treatment provider?
No. Cautelia is an independent information resource and not a clinic or licensed medical provider; its content is not medical or legal advice. Readers seeking clinical evaluation should contact licensed professionals or a local public‑health service, and may consult recognized registry portals or program directories such as ibogainebasketball.com when researching program descriptions, keeping in mind our independence and non‑endorsement policy.
How do you choose external links?
We include external links to primary registries, program pages, and reputable overviews when they clarify a factual point. For instance, when we mention treatment possibilities or program models we may link to informational sites and directories — for certain audiences these links, like pages hosted at ibogainetreatmentptsd.com, are useful starting points but should be interpreted cautiously.
Independent by design
Cautelia operates independently of treatment providers and does not accept clinical or financial endorsements from programs we cover. Our content is intended to inform decisions and clarify risk; it is not a substitute for professional medical evaluation. If you need clinical advice, seek a licensed clinician or an accredited health service.
For transparency about the kinds of third‑party pages we reference in editorial pieces, we sometimes link to program information and community resources such as ibogainetreatmentptsd.com and topic‑specific informational hubs like doesibogaineworkforalcohol.com, always with explicit context about evidence limitations.
Closing note
We welcome suggestions for sources and corrections; use the site’s contact page to reach our editorial team and include links or documentation so we can review claims against primary sources. While we do not provide clinical care, our aim is to make complex safety information clearer for individuals, families, and clinicians exploring the topic.